These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2021929)

  • 1. Changes in plasma gangliosides in relation to tumor growth modified by vitamin A.
    Saha S; Ghosh A
    Cancer Lett; 1991 Mar; 56(3):251-8. PubMed ID: 2021929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in plasma gangliosides in relation to tumor growth and their tumor-enhancing effect.
    Saha S; Chattopadhyay U
    Int J Cancer; 1988 Mar; 41(3):432-5. PubMed ID: 3346109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of plasma gangliosides on the growth of Ehrlich ascites tumor.
    Saha S; Ghosh A
    Int J Cancer; 1990 Oct; 46(4):691-4. PubMed ID: 2210885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of Ehrlich subcutaneous solid tumor growth by immunization with ganglioside GT1b of its origin, its IgM antibody or anti-idiotype antibody.
    Saha S; Mondal S
    J Exp Clin Cancer Res; 2001 Mar; 20(1):75-84. PubMed ID: 11370834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship between the ganglioside composition of Ehrlich ascitic carcinoma and cell population density].
    Prokazova NV; Kocharov SL; Zvezdina ND; Shaposhnikova GI; Buznikov GA
    Biokhimiia; 1978 Oct; 43(10):1805-8. PubMed ID: 719051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of Ehrlich ascites tumor growth by immunization with ganglioside GT1b of its origin, its IgM antibody or anti-idiotype of the anti-GT1b IgM.
    Saha S; Mondal S
    Indian J Exp Biol; 2000 Dec; 38(12):1207-16. PubMed ID: 11411041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of subcutaneous growth of Ehrlich ascites carcinoma (EAC) tumor by post-immunization with EAC-cell gangliosides and its anti-idiotype antibody in relation to tumor angiogenesis, apoptosis, cell cycle and infiltration of CD4+, CD8+ lymphocytes, NK cells, suppressor cells and APC-cells in tumor.
    Mondal B; Saha S
    Indian J Exp Biol; 2011 Aug; 49(8):574-84. PubMed ID: 21870425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of vitamin A compounds on DNA biosynthesis in murine tumor models in vitro.
    Satyamoorthy K; Chitnis MP
    Oncology; 1987; 44(6):356-9. PubMed ID: 3684177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neutral glycosphingolipids in Ehrlich ascites carcinoma cells].
    Prokazova NV; Kocharov SL; Isaev IV; Fomina-Ageeva EV; Shaposhnikova GI
    Bioorg Khim; 1984 Feb; 10(2):238-43. PubMed ID: 6487391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sunflower seed oil-enriched product can inhibit Ehrlich solid tumor growth in mice.
    Silva LA; Nascimento KA; Maciel MC; Pinheiro MT; Sousa PR; Ferreira SC; Azevedo AP; Guerra RN; Nascimento FR
    Chemotherapy; 2006; 52(2):91-4. PubMed ID: 16462141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor inhibition and hematological improvements by dopamine analog 3,4-dihydroxybenzylamine in mice bearing transplantable carcinoma.
    Lahiri T; Banerjee S; Dasgupta PS; Ray MR
    Neoplasma; 1990; 37(4):387-93. PubMed ID: 2234200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caffeine enhances adriamycin antitumor activity in Ehrlich ascites carcinoma-bearing mice.
    Sadzuka Y; Mochizuki E; Iwazaki A; Hirota S; Takino Y
    Biol Pharm Bull; 1995 Jan; 18(1):159-61. PubMed ID: 7735232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and pathological studies on the effects of levamisole and chlorambucil on Ehrlich ascites carcinoma-bearing mice.
    Salem FS; Badr MO; Neamat-Allah AN
    Vet Ital; 2011; 47(1):89-95. PubMed ID: 21240854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of haloperidol, bromocriptine and amphetamine on the development of Ehrlich ascites carcinoma in mice.
    Frussa-Filho R; Monteiro Mdo C; Soares CG; Décio RC
    Pharmacology; 1992; 45(1):58-60. PubMed ID: 1508968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Ehrlich ascites carcinoma (EAC) growth by carbonyl iron.
    Pessina A; Brambilla P; Balzarin D
    Experientia; 1978 Nov; 34(11):1518-9. PubMed ID: 720492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of hydroxynitrodihydrothymine on the growth of Ehrlich ascites tumor cells.
    Mustea I; Bara A; Comes R; Postescu ID
    Cancer Treat Rep; 1978 May; 62(5):823-7. PubMed ID: 26466
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of a Titanocene Dichloride derivative, Ti IV (C5H5)(2) NCS(2), on the haematopoietic response of Ehrlich tumour-bearing mice.
    Valadares MC; Queiroz ML
    Eur J Pharmacol; 2002 Mar; 439(1-3):35-42. PubMed ID: 11937090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extraction and purification of gangliosides from plasma and fibroblasts before analysis by thin layer chromatography.
    Leenders RG; de Jong JG; Wevers RA
    Ann Clin Biochem; 1995 Jan; 32 ( Pt 1)():68-73. PubMed ID: 7762953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and purification of gangliosides from plasma.
    Ladisch S; Gillard B
    Methods Enzymol; 1987; 138():300-6. PubMed ID: 3600328
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of Hep2 and HeLa cell proliferation in vitro and EAC tumor growth in vivo by Lapemis curtus (Shaw 1802) venom.
    Karthikeyan R; Karthigayan S; Sri Balasubashini M; Somasundaram ST; Balasubramanian T
    Toxicon; 2008 Jan; 51(1):157-61. PubMed ID: 17936322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.